Cellular therapies for neurodegenerative diseases.
We are confident that neurodegenerative diseases will be managed by an array of pharmacologic and cellular therapies. These may involve oral or intravenous preparations, surgical cell deliveries, or infusion through cerebral delivery systems. Achievements in neuroscience over the past three decades have redefined some of the rules for basic and clinical research in neurotransplantation. Restorative neurosurgical procedures will develop from different directions, and it is likely that a combination of approaches will be necessary to maximize patient outcomes.
Kondziolka
D
D
Department of Neurological Surgery, Neurotransplantation Research Program, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Tyler-Kabara
E
E
Achim
C
C
D016332:Fetal Tissue Transplantation; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D019636:Neurodegenerative Diseases / Q000628:therapy*; D019635:Neurosurgical Procedures / Q000379:methods*; D033581:Stem Cell Transplantation